Cannabis and Tobacco Co-use Study

Phase 4 Completed 181 enrolled Medical University of South Carolina National Cancer Institute (NCI) · collab National Institutes of Health (NIH) · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to better understand tobacco outcomes using a well-known stop smoking medication, varenicline, and financial incentives with tobacco users. The investigators are also interested in how cannabis/marijuana and tobacco interact during a tobacco quit attempt. All participants will receive tobacco cessation treatment (varenicline) for 12 weeks. This study will recruit adult tobacco users (ages 18-40) who are motivated to quit smoking cigarettes.

Timeline

Start: 2020-01-28
Primary completion: 2024-06-12
Completion: 2024-09-13

Publications

Walters KJ, Baker NL, Tomko RL, Gray KM, Carpenter MJ, McClure EA. Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial. BMC Psychol. 2023 Jan 25;11(1):25. doi: 10.1186/s40359-023-01060-2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Varenicline	Small molecule	2 mg	—

Cannabis and Tobacco Co-use Study

Summary

Timeline

Publications

Drugs

Indications